1 rich Libsyn https://www.libsyn.com 90 600 In this week’s View, Dr. Eagle highlights&amp;nbsp;trials&amp;nbsp;from the recently held&amp;nbsp;ACC&amp;nbsp;Scientific Sessions&amp;nbsp;which took place&amp;nbsp;in New Orleans,&amp;nbsp;March 28-30.&amp;nbsp;Important studies discussed include:&amp;nbsp;&amp;nbsp; CHAMPION-AF: Left&amp;nbsp;atrial&amp;nbsp;appendage&amp;nbsp;closure vs.&amp;nbsp;anticoagulation&amp;nbsp;for&amp;nbsp;AFib&amp;nbsp;&amp;nbsp; VESALIUS-CV:&amp;nbsp;Evolocumab&amp;nbsp;reduces CV&amp;nbsp;risk in&amp;nbsp;diabetic&amp;nbsp;patients&amp;nbsp;without ASCVD&amp;nbsp; Ez-PAVE:&amp;nbsp;Hitting&amp;nbsp;lower LDL-C&amp;nbsp;target&amp;nbsp;reduces&amp;nbsp;major CV&amp;nbsp;events&amp;nbsp;&amp;nbsp; PRO-TAVI: Should&amp;nbsp;high-risk&amp;nbsp;patients&amp;nbsp;undergo PCI&amp;nbsp;before TAVI?&amp;nbsp;&amp;nbsp; SMART-DECISION:&amp;nbsp;Discontinuing&amp;nbsp;beta-blockers&amp;nbsp;safe 1&amp;nbsp;year&amp;nbsp;post MI For&amp;nbsp;stable&amp;nbsp;patients&amp;nbsp; GoFreshRx:&amp;nbsp;How home-delivered DASH groceries improve blood pressure&amp;nbsp;(BP)&amp;nbsp;and LDL-C&amp;nbsp; THRIVE:&amp;nbsp;Exploring the positive effects of a culturally tailored “food-is medicine” program on lowering&amp;nbsp;BP&amp;nbsp; &amp;nbsp;  &amp;nbsp; Eagle's Eye View: Your Weekly CV Update From ACC.org http://www.acc.org <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/40766465/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/200539085